Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

• Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2018
• Descrizione fisica: 1 online resource (v, 136 pages) : illustrations
• Soggetto topico: User charges - Law and legislation; Prescription pricing - Law and legislation; Generic drugs - Prices; Drugs - Law and legislation; Generic drugs - Prices - United States; Prescription pricing - Law and legislation - United States; User charges - Law and legislation - United States; Drug accessibility - Government policy - United States; Drugs - Law and legislation - United States
• Soggetto geografico: United States
• Soggetto genere / forma: Rules.; Legislative hearings.
• Note generali: "Serial No. 115-10."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Examining FDA's generic drug and biosimilar user fee programs
• Titolo autorizzato: Examining FDA's generic drug and biosimilar user fee programs
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910716666403321
• Lo trovi qui: Univ. Federico II